Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-29 @ 12:59 AM
Study NCT ID:
NCT01250834
Status:
COMPLETED
Last Update Posted:
2014-10-08
First Post:
2010-11-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LY2189265 and Atorvastatin Interaction Study
Sponsor:
Eli Lilly and Company
Organization:
Study Overview
Official Title:
Effect of LY2189265 on the Pharmacokinetics of Atorvastatin in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess if giving LY2189265 at the same time as atorvastatin affects how the body absorbs atorvastatin.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: